This inventor holds 1 USPTO granted patent. Top assignee: Tohoku University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Nobuo Cho: Innovator in Heterocyclic Compounds
Introduction
Nobuo Cho is a distinguished inventor based in Fujisawa, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds that have potential applications in medical science. His innovative work focuses on compounds that can induce degradation by autophagy of intracellular molecules.
Latest Patents
Nobuo Cho holds a patent for a heterocyclic compound. This patent describes a novel compound or salt that effectively induces degradation by autophagy of an intracellular molecule. The compound features a ligand that binds to an intracellular molecule, linked via a linker to a structure that induces autophagy, all while maintaining the activity of both the ligand and the structure. This innovative approach has the potential to advance therapeutic strategies in various medical fields.
Career Highlights
Nobuo Cho is affiliated with Tohoku University, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on drug development and cellular biology. With a focus on enhancing the understanding of autophagy, Cho's research is paving the way for new therapeutic avenues.
Collaborations
Nobuo Cho collaborates with notable colleagues, including Hiroshi Nara and Kaori Itto. These partnerships enhance the scope and depth of his research, contributing to the advancement of knowledge in their shared field of study.
Conclusion
Nobuo Cho is a prominent figure in the realm of heterocyclic compounds, with a patent that showcases his innovative approach to inducing autophagy. His work at Tohoku University and collaborations with esteemed colleagues highlight his commitment to advancing scientific knowledge. The implications of his research are significant, potentially leading to breakthroughs in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
